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Background: Side population (SP) assay identifies cells with dye/drug extrusion ability, a characteristic of stem cells.
Here, we determined if SP cells exist in a verified cell line originating from recurrent nasopharyngeal carcinoma (NPC)
and a xenograft established from recurrent metastatic NPC. These cells were evaluated for stem-like properties via
functional assays as well as for tumourigenicity.
Methods: We used Hoechst 33342 to identify the SP from non-SP (NSP) cells in HK1 NPC cell line and xeno-284
NPC xenograft. The cells were assayed for in vitro characteristics of cancer stem cells (CSC), gene expression and
tumourigenicity ability. Student’s t test was used to test for significance.
Results: Five to ten percent and less than 0.5% of HK1 and xeno-284 NPC cells, respectively, were SP cells.
Fumitremorgin C (FTC), as opposed to verapamil, was effective in causing the cells to retain Hoechst 33342 dye.
HK1 SP cells formed more holoclones, had more aldehyde dehydrogenase (ALDH) activity, divided asymmetrically and
contained slow-proliferating cells. ABCG2, SOX2, TERT, MYC, Hedgehog, Notch, TGFβ and Wnt signalling pathway genes
were significantly upregulated in the SP cells. However, despite these differences in vitro, both HK1 SP and NSP cells
had an overall similar tumourigenic potential in vivo.
Conclusions: HK1 SP cells were ABCG2-specific as confirmed by FTC inhibition and gene expression data. Despite data
from in vitro and gene expression experiments suggesting stem-like features, there was no significant difference in
tumourigenic potential between SP and NSP cells. We conclude that SP assay alone is not sufficient to identify CSCs in
HK1 cells. Our work also suggests the presence of a stem-cell like population among NPC cells which do not display
increased tumourigenicity.
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Nasopharyngeal carcinoma (NPC) is the most common
malignancy arising from the nasopharynx and its caus-
ation is closely associated with the Epstein-Barr virus, en-
vironmental as well as dietary factors [1]. Majority of NPC
cases present in late stages [2]. The late presentation of
the disease is due to the hidden location of the tumour,
which could present with either no or apparently trivial
symptoms which could be dismissed by patients or even
medical professionals [3]. In addition, disease recurrence,* Correspondence: alankhoo@imr.gov.my
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unless otherwise stated.therapeutic resistance and metastasis remain major clin-
ical problems [4].
The cancer stem cell (CSC) model hypothesizes that
there is a hierarchy within the tumour cell population
and only a rare subset of cancer cells has the ability to
self-renew and to differentiate, leading to the recapitula-
tion of the original tumour [5]. As such, the spread of
CSCs is an important component of the process of me-
tastasis and, reactivation of CSC proliferation is believed
to be the underlying cause of disease recurrence.
CSCs are found to behave differently from the rest of
tumour cells; amongst others, they have enriched tumour-
forming potential, and have efficient drug extrusion sys-
tems to evade most chemotherapeutic drugs [6]. These
cells undergo asymmetric divisions to give rise to daughter. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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does not show stem cell characteristics. Some CSC-
enriched subpopulations were slower in proliferation
(reviewed in Moore et al. [7]), whilst others reported
an equal or rapid proliferation rate than the non-CSC
subpopulations [8,9].
As drug extrusion is one of the properties for CSC,
several groups had adapted the original side population
(SP) assay by Goodell et al. [10] for identification of pu-
tative stem cells and progenitors in solid tumours [11-13].
The ability of SP cells to extrude the Hoechst 33342 dye,
causing them to appear as a dimly stained side population
in flow cytometry dot plots, is dependent on the activity of
the ATP-binding cassette (ABC) transporter family which
includes ABCB1, ABCC1 and ABCG2 [14]. Verapamil is a
potent inhibitor for ABCB1 which also weakly inhibits
ABCG2 activities, while fumitremorgin C (FTC) specific-
ally inhibits ABCG2 [15,16]. By adding one of these inhibi-
tors into the SP assay, one can determine the type of ABC
transporter protein which is responsible for the dye ex-
trusion activity. Prior to this report, there was an earlier
publication on the use of SP assay in well- and poorly-
differentiated NPC cell lines which indicated that puta-
tive CSC in these cell lines may be related to ABCB1
activities [17]. However, in vivo tumourigenicity assay
was performed for only 4 weeks and the identity of the
cell line chosen to perform downstream functional ex-
periments was questioned in a later publication [18].
NPC HK1 is a cell line established from a well-
differentiated recurrent NPC sample [19], while xeno-
284 is a xenograft line established in our laboratory from a
poorly differentiated recurrent metastatic NPC sample. In
this study, we first tested for the presence of the SP sub-
population in HK1 and xeno-284 NPC cells, followed
by sorting of SP and non-SP (NSP) subpopulations for
comparison of in vitro clone morphology, cell division
and proliferation. Aldehyde dehydrogenase (ALDH) flow-
staining was carried out to determine the level of ALDH
activity in the sorted cells. Gene expression studies were
also performed to identify stem cell related genes and
pathways which may be responsible for the observations.
Finally, in vivo tumourigenicity experiments were performed
for duration of up to 7 weeks to evaluate the tumour-
initiating ability of SP and NSP cells.
Results
HK1 contains SP cell subpopulation
The identity of the HK1 NPC cells used was validated by
short tandem repeat (STR) profiling to be identical to
the HK1 cells used by others [18] (Additional file 1).
The SP phenotype as identified by low Hoechst 33342
blue/red fluorescence intensity was detected in 5-10% of
HK1 cells (Figure 1). The loss of the SP population with
addition of FTC but not verapamil, suggested that ABCG2was the functional ABC transporter in these SP cells
(Figure 1). Compared to HK1, xeno-284 cells had very
few (less than 0.5%) or no SP cells during replicate
runs (Figure 1). As such, only HK1 SP and NSP cells
were used for subsequent downstream experiments.
HK1 SP cells form holoclones during in vitro culture
Sorted SP and NSP cells exhibited different growth pat-
terns. After a week of in vitro culture in fully-supplemented
RPMI medium, most of the SP cells grew into holoclones
which formed tightly-clustered cells with well-defined clone
borders (Figure 2A). Clones established by the NSP cells
primarily consisted of slightly-scattered cells with irregular
borders (meroclones) and/or tiny clusters of cells which
did not display much growth (paraclones) (Figure 2B). Re-
peated experiments showed that SP cells formed more
holoclones than NSP cells (p < 0.0001; Figure 2C).
HK1 SP cells express higher aldehyde dehydrogenase
activity
The ALDEFLUOR staining kit used in this study detects
the enzymatic activity of ALDH1, a marker of stemness
[20]. Cells incubated with the ALDEFLUOR substrate
(BAAA) and the ALDH inhibitor (DEAB) were used to
define the ALDHbright region (representative plots as shown
in Figure 2D). The SP cells showed a significantly higher
population of ALDHbright cells (18.08 ± 11.46%) than NSP
cells (5.10 ± 3.56%) (Figure 2E).
HK1 SP cells divide asymmetrically into SP and NSP cells
during in vitro culture
The ability of SP and NSP cells to grow and divide asym-
metrically in vitro was examined by re-evaluating the
percentages of SP and NSP fractions in the sorted cells.
After three weeks of culture, the SP sorted cells had di-
vided into both SP and NSP cells, with only 24.57 ± 7.97%
of the cells still remaining as SP cells. On the other hand,
6.07 ± 1.74% of SP cells had reappeared in the NSP sorted
cells (Figure 3A).
HK1 SP cells proliferate slower than NSP cells
There was a significant difference in the normalized growth
rates between SP and NSP cells in the impedance-based
assay (p < 0.0001; Figure 3B). SP cells grew at a slower rate
as compared to NSP cells especially at the first 72 hours of
observation. At the end of the experiment, growth rates
of the SP cells and NSP cells were getting similar to the
growth rate of control cells.
Analysis of stem cell related genes in HK1 SP and NSP cells
A total of 168 genes related to stem cell identification
and/or involved in key stem cell pathways were analysed
by quantitative RT-PCR. Fifty genes were significantly
upregulated by at least 2 fold in SP cells compared to
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Figure 1 Identification of side population in NPC cells. Representative dot plots of HK1 and xeno-284 NPC cells stained with Hoechst 33342
dye, with and without inhibitor. The inhibitory effect of FTC at 1 μM was more evident in HK1 cells as compared to verapamil at both concentrations
of 50 and 100 μM. ND: not done.
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and, members of the Hedgehog (GLI1-3, PTCH1, PTCHD2
and SUFU), Notch, TGFβ (ACVR1B, SMAD1, SMAD7 and
LTBP2-3) and Wnt (FZD2, FZD6-7, BCL9 and BCL9L)
signalling pathways (Figure 4; Additional file 2). None
of the genes tested were significantly downregulated in
SP cells.
HK1 SP subpopulation does not display significant
enrichment for tumour-initiating cells in an in vivo
xenograft assay
As the in vitro experiments suggested that the SP sub-
population enriched for cells with stem-like phenotype,
we proceeded to determine whether this subpopulation
would enrich for tumour-initiating cells in an in vivo assay.
A pilot study showed that 1000 unsorted HK1 cells
could form tumours in nude mice (data not shown). To
determine the tumour-forming ability of SP and NSP cells,
1000, 100 and 10 cells were inoculated subcutaneouslyinto nude mice (Figure 5A). Three out of four tumours
from inoculation of 10 SP cells which were detected earlier
than the first tumour from inoculation of NSP cells of the
same number suggested that SP cells may have a growth
advantage compared to NSP cells. The growth advantage
was however lost at higher inoculations of 100 and 1000
cells. Limiting dilution analysis using the Extreme Limit-
ing Dilution Analysis (ELDA) software showed that the
estimated number of tumour-initiating cells based on the
in vivo assay was not significantly different between the SP
and NSP subpopulations, implying that the difference in
the potential of SP and NSP cells to form tumours was
not significant (Figure 5B). Both SP and NSP tumours
showed similar histomorphology as seen in unsorted HK1
cells grown in mice (Figure 5C). Histologically, there was
also no substantial difference between SP and NSP tu-
mours in the degree of differentiation, stromal reaction
and cell pleomorphism (Figure 5D), except for one SP












Figure 2 SP subpopulation enriches for stem-cell like phenotype in in vitro assays. (A) During in vitro culture, majority of SP cells formed
holoclones with individual cells clustering tightly and forming a well-defined clone border. (B) NSP cells tended to form loose clusters of meroclones
or, paraclones (inset) with tiny clusters of cells situated far from each other. All photos were taken on day 9 post-sorting; original magnification 100X.
(C) SP cells formed more holoclones than NSP cells during in vitro culture (p < 0.0001). (D) The gating for the ALDHbright population was set
by a control tube with the addition of DEAB, an ALDH inhibitor. (E) SP cells showed higher presence of ALDHbright cells (18.08 ± 11.46%) than
NSP cells (5.10 ± 3.56%) (p < 0.05).
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CSCs are frequently identified by the presence of surface
antigens/markers associated with self-renewal, differenti-
ation, proliferation, metastasis and/or drug resistance char-
acteristics, having increased ALDH activity or through their
ability to extrude drugs by ABC transporters. However,
these approaches may not be universal in identifying the













Figure 3 SP cells grow at a slower rate compared to NSP cells. (A) Up
SP cells had divided asymmetrically into SP and NSP phenotypes. Recultured
growth assay indicated that the normalized growth rate for SP cells was lowe(reviewed in [21]). In NPC, different CSC markers had
been reported from the same cell lines generated from
primary NPC cases (Additional file 3) [17,22-25]. In this
study, we aim to evaluate the presence of CSCs in a cell
line established from recurrent NPC by the SP approach.
Results from our various in vitro-based assays indicate
that the SP cells of HK1 were stem-like. During a week’s
growth in fully-supplemented RPMI medium, both SP andB



















on relabelling with Hoechst 33342 on day 21 post-sorting, recultured
NSP cells had poorer asymmetric division ability. (B) Impedance-based cell
























Figure 4 SP subpopulation enriches for cells expressing stem-cell related genes. Combined data from Stem Cell PCR Array and Stem Cell
Signaling PCR Array were clustered according to gene function or signaling pathways. Gene expression data were normalized to five housekeeping
genes via geometric mean calculation. Only genes which were significantly upregulated by at least 2 fold, with raw Ct values of less than 35 are shown
here. None of the downregulated genes fulfilled the selection criteria of at least 2 fold change and p < 0.05. Some of the genes appeared in more than
1 gene function or signaling pathway (refer to Additional file 2 for details).
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in in vitro culture. SP cells grew into tightly packed clus-
ters of holoclones, a particular clonal growth morphology
closely associated with stem cells and self-renewal ability,
as opposed to NSP cells which mostly grew as meroclones
and/or paraclones [26-28]. SP cells in HK1 were also found
to be significantly enhanced with ALDH activity, which is
known to enhance cancer cell survival and therapy resist-
ance [20]. Gene expression analysis showed upregulation
of ABCG2 mRNA level in HK1 SP cells which further
indicated the type of ABC transporter being studied
here. These SP cells also showed increased mRNA levels
for SOX2, MYC and TERT which were associated with
CSC biology and maintenance of pluripotency state [29,30].
Over-expression of Hedgehog pathway genes such as GLI1,
GLI2, GLI3FL, PTCH1 and PTCHD2 was in line with
reports that Hedgehog pathway can induce ABCG2 ex-
pression [31] and it was activated in stem-like cells in EBV
positive NPC [23,32].
Nonetheless, there were other findings in our study
which seemingly suggested that the stem-like character-
istic of SP cells in HK1 may be transient. SP cells of
HK1 grew slower in culture which is in line with reports
that CSCs from various tumours had slower proliferation
rate and hence evaded chemotherapeutic agents which
targeted fast growing cells [33,34]. However, the slower
rate gradually diminished after a week (Figure 3B). Also, in
long term culture, NSP cells gave rise to SP cells (Figure 3A).
Together, these two time course in vitro experiments
(proliferation assay and asymmetry assay) indicated thatthe difference between SP and NSP sorted cells may be
transient, as both type of cells could interconvert [17,35].
The indication that SP cells can only maintain a transi-
ent stem-like phenotype in HK1 might well explain the
discordance of our in vitro results with in vivo results.
Although there was a growth advantage of SP cells in
the lowest inoculation group of mice, an overall compar-
able tumourigenic potential of both SP and NSP cells
was recorded after 7 weeks of in vivo transplantation
(Figure 5). The discordance of in vitro and in vivo results
is not uncommon, as it has been reported in studies utiliz-
ing SP approach to identify CSC in thyroid cancer [36]
and cervical cancer [37] as well as studies using marker
approach to identify CSC in NPC [25] and colorectal
cancer [38]. In our study, although HK1 SP cells were
significantly enriched for ALDHbright cells, there were 5%
of ALDHbright cells in NSP cells. Wu et al. had reported
that ALDH positive cells are CSCs in NPC [22]. If ALDH
positive cells were also CSCs in recurrent NPC, this would
lend credence to our observation of HK1 NSP cells’ ability
to generate tumour growth may be partially due to the
subset of ALDH positive cells in them.
Our negative findings in in vivo study suggested that
SP approach in HK1 cells only enriches for a certain sub-
type with stem-cell features but not bona fide CSCs as
depicted by both SP and NSP subpopulations’ ability to
confer tumour growth in mice. This is in contrast to an
earlier report that showed significant tumour growth differ-
ence of SP cells over NSP cells in NPC [17]. The disparity
may be related to firstly, the type of NPC cell line being
Acell phenotype number of tumours/number of mice TIC frequency (95% CI)
1000 cells 100 cells 10 cells
SP 12/12 8/12 4/11 1/66 (1/35 – 1/126)









Figure 5 In vivo tumour growth analysis of SP and non-SP (NSP) cells isolated from HK1 NPC cell line. (A) SP or NSP cell inoculation in
nude mice. Distinct difference in tumour latency was observed in the lowest inoculated cell number (10 cells). (B) Limiting dilution analysis of SP
and NSP tumours. Tumour-initiating cells (TICs) were similarly enriched in both SP and NSP cells (p > 0.05). (C) Representative gross morphology
of tumours inoculated with (i) 1000 SP cells, (ii) 1000 NSP cells, (iii) 100 SP cells, (iv) 100 NSP cells, (v) 10 SP cells and (vi) 10 NSP cells. (D) H & E
photos of tumours after inoculated into nude mice with (i) unsorted HK1 cells, (ii) SP cells and (iii) NSP cells. Tumours derived from SP and NSP
cells showed similar histomorphology to unsorted HK1 cells (black arrowhead pointing to squamous carcinoma; long arrow pointing to keratinization).
(iv) A SP cell derived tumour showed vascular invasion (white arrowhead pointing to the invasion of SP cells into a blood vessel). All photos at original
magnification 400X.
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reported to be contaminated with a partial genome of
HeLa, whereas HK1 NPC cells used in this study was
verified by STR profiling to be free from HeLa cell con-
tamination [18]. Secondly, we used FTC as a dye efflux
inhibitor to identify ABCG2-specific SP cells from HK1
and xeno-284 cells, instead of verapamil, a classic inhibitor
for ABCB1-expressing cells [15,16] which showed no in-
hibition in our study but was used in the above mentioned
study [17]. Our negative finding was in line with Zhang
et al. which reported that ABCG2 was not a CSC marker
for NPC [25]. Lastly, the length of tumour assessment
time in in vivo was different. Mice inoculated with CNE-2
SP and NSP cells were euthanized 4 weeks after inocula-
tion, whereas our mice were observed for 7 weeks. Asthe incubation time was relatively short, there remains
a possibility of CNE-2 NSP cells giving rise to tumour
in mice after 4 weeks of inoculation.
Conclusions
Our study shows that ABCG2-specific SP cell subpopu-
lation is found in HK1 NPC cells, a cell line generated
from well-differentiated recurrent NPC but they are min-
imal in xeno-284 cells, a xenograft derived from poorly
differentiated metastatic NPC. In spite of in vitro evidence
proposing that CSCs from HK1 can be identified by the
SP approach, in vivo validation study showed that both SP
and NSP cells of HK1 had similar tumourigenicity poten-
tial. Therefore, we conclude that the SP approach alone
cannot identify CSCs accurately in HK1 cells.
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Cell line and culture conditions
HK1 NPC cells were cultured in fully-supplemented RPMI
1640 medium containing 10% fetal calf serum and 1%
penicillin/streptomycin (Gibco, NY, USA) in a 5% CO2
incubator at 37°C. The cells were confirmed to be
mycoplasma-free by periodical testing with Venor GeM
Mycoplasma Detection Kit for Conventional PCR (Minerva
Biolabs, Berlin, Germany).
Digestion of xenograft sample
Xeno-284 NPC xenograft was freshly harvested and rinsed
with cold sterile PBS supplemented with 1X antibiotic/
antimycotic (Gibco, NY, USA). After removing visible
blood capillaries and/or necrotic tissue, the xenograft
tissue was minced finely in the presence of 1X collagenase/
dispase solution (Roche, Mannheim, Germany). The mix-
ture was incubated for 60 min in a 5% CO2 incubator at
37°C with constant agitation. The cell suspension and
undigested xenograft pieces were separated by sieving
through 40 μm cap strainer. After a brief centrifugation
step, the cell pellet was resuspended in RBC lysis buffer
(Qiagen, Hilden, Germany) and, the cells were rinsed
with sterile PBS prior to cell count and viability check.
Hoechst 33342 staining assay
HK1 NPC cells at a logarithmic growth phase were de-
tached by Accutase (Millipore, MA, USA) and washed at
least once with PBS prior to Hoechst 33342-staining. A
modification of Goodell’s method was used to stain both
HK1 and xeno-284 NPC cells [10]. Briefly, the cells were
re-suspended at a concentration of 1 × 106 cells per mL
in warm HBSS buffer (Gibco, NY, USA) supplemented
with 2% fetal calf serum and 10mM HEPES (“HBSS+”).
Hoechst 33342 dye (Molecular Probes, OR, USA) was
added into the cell suspension at a final concentration of
5 μM in the presence or absence of the ABCG2 inhibi-
tor, fumitremorgin C (FTC) at a final concentration of 1
μM (Sigma, MO, USA) or verapamil (ABCB1 inhibitor)
at a final concentration of 50 and 100 μM (Sigma, MO,
USA). The cells were incubated for 90 min in a 37°C
water bath with intermittent mixing. Excessive Hoechst
33342 dye was removed from the cell suspension by
washing with cold HBSS+. The resulting pellet was re-
suspended to a final concentration of 1 – 2 × 106 cells
per mL with cold HBSS+. In order to delineate host mouse
cells, xeno-284 cells were further stained with H2Kd-PE
antibody (1:10, BD Pharmingen, MA, USA) for 30 min at
4°C. Propidium iodide (PI, 2 μM, BD Pharmingen, MA,
USA) was added to stained HK1 NPC cells and, 7-AAD
(BD Pharmingen, MA, USA) to Hoechst-stained xeno-284
cells for determination of cell viability. The stained cells
were analyzed and sorted in a BD FACSAria II SORP
cytometer (BD Biosciences, MA, USA) equipped with a355 nm-UV laser power of 50 mW. The Hoechst 33342
fluorescence was detected via a 405/20 band-pass filter
(Hoechst Blue) and a 670 long pass filter (Hoechst Red).
The sorted SP and NSP cells were collected in fully-
supplemented RPMI medium. Presence of cells is re-
ported as percentages of single, viable SP or NSP cells.
Subsequent experiments were performed using HK1
NPC cells as xeno-284 NPC xenograft had too few SP
cells for sorting.
Clone morphology assay
Sorted cells were plated at a low cell density of 50 cells
per well in a 96-well culture plate containing fully-
supplemented RPMI medium. Upon seeding, microscopic
inspection of each well was performed to ensure there
was no cell clumping. Once the cells were adherent, the
culture medium was changed every two days. The numbers
of holoclones, meroclones and paraclones were counted
on day 8 post-sorting. Data were recorded from three inde-
pendent experiments with 12 replicate wells per SP or NSP
cells in each experiment.
Aldehyde dehydrogenase (ALDH) assay
Sorted cells were left for overnight recovery in the culture
conditions as mentioned above. The cells were detached
using Accutase and ALDH staining was performed with
the ALDEFLUOR staining kit (Stem Cell Technologies,
Vancouver, Canada). Briefly, 0.25 × 106 cells were resus-
pended in ALDEFLUOR assay buffer containing 1.5 μM
ALDH activated substrate, BAAA and incubated for
45 mins at 37°C. Half of each sorted sample was treated
with 15 μM DEAB, an inhibitor of ALDH. The stained
cells were washed, resuspended in cold ALDEFLUOR
assay buffer containing 2 μM PI and analyzed in BD
FACSCalibur (BD Biosciences, MA, USA). Data were ob-
tained from five independent experiments.
Asymmetric division assay
Ten thousand sorted cells were recultured for three weeks
in fully-supplemented RPMI medium. Hoechst 33342 stain-
ing was performed as described above, and the cells were
analyzed in a BD FACSAria II SORP cytometer. Data were
recorded from three independent experiments.
Proliferation assay
Sorted cells were left to recover from the sorting process
in a 5% CO2 incubator at 37°C for approximately two
hours. The “recovered” cells were seeded at 3000 cells
per 200 μL into each well of the E-plate 16 (Roche,
Mannheim, Germany). Cell index values were recorded
over a period of 125 hours with an interval of 1 hour for
the first day, followed by every 6 hours for the remaining
experiment by the xCELLigence System’s Real time Cell
Analyzer (RTCA) DP instrument (Roche, Mannheim,
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of electrical impedance of monitored cells which reflect
cell growth (number and viability), morphology and adhe-
sion ability. The cell index values of SP and NSP cells at
each time point were then normalized to the control cells
(HK1 cells which were only stained with PI and sorted
from PI negative gate). Data were obtained from three in-
dependent experiments.
Stem cell gene expression study
Quantitative RT-PCR was performed using Human Stem
Cell and Stem Cell Signalling PCR Arrays (SABiosciences,
MD, USA). Total RNA was isolated using TRIzol (Invitrogen,
CA, USA) and cleaned with RNeasy extraction kit (Qiagen,
CA, USA). The quality and concentration of the ex-
tracted RNA was determined with NanoDrop 8000 spec-
trophotometer (Thermo Scientific, DE, USA) and only
samples with a 260/280 ratio of ~ 1.8 were used for reverse
transcription. Total RNA (100 ng) was reverse-transcribed
using the accompanying First Strand Synthesis Kit and
cDNA was amplified using SYBR green/ROX master mix
in the ABI7500 Fast Real-Time thermal cycler (Applied
Biosystems, CA, USA). Genes with Ct values of more than
35 were removed from analysis. Ct value of each gene was
normalized against the geometric mean Ct value of five
housekeeping genes (Ct geoHK), with the formula 2
-dCt
(dCt = Ct gene of interest – Ct geoHK). The normalized
×values were used to calculate fold change ratios be-
tween SP and NSP. Data were obtained from three in-
dependent experiments.
In vivo tumourigenecity assay
Inoculations of SP and NSP cells into nude mice were
performed in a limiting dilution manner: 1000, 100 and
10 cells. Sorted cells were mixed with BD Matrigel Base-
ment Membrane Matrix (BD Biosciences, MA, USA) and
inoculated subcutaneously into 5 – 6-week-old nude mice
(Balb/c nu/nu). Tumour latency data, defined as the
period between the inoculation day to the first day of
tumour detection, were recorded. Once a palpable growth
was detected, tumour volume was recorded every two days.
Tumour volume (mm3) was calculated from 0.5 × (width ×
length2). All tumours were harvested once the length or
width reached 10 mm or on day 50 post-inoculation. Limit-
ing dilution analysis was performed using the Extreme Lim-
iting Dilution Analysis (ELDA) software (http://bioinf.wehi.
edu.au/software/elda/). Data for each group were from
three independent experiments. All mice experiments were
approved by the Animal Care and Use Committee of the
Ministry of Health, Malaysia.
Haematoxylin and eosin (H & E) staining
Four-micrometre formalin-fixed, paraffin-embedded tissue
sections from SP and NSP tumours were mounted on plainglass slides and stained with H & E. Histopathological
observations were made under a light microscope by a
pathologist and all tumours were confirmed to be NPC.
Statistical analysis
Data are reported as the mean ± standard deviation (SD)
or boxplot with whiskers showing the 5 - 95 percentile. All
statistical analyses were performed using paired Student’s
t test from the GraphPad Prism 5 software (GraphPad
Software Inc., CA, USA), except for clone morphology
which used unpaired Student’s t test. A p-value of < 0.05
was deemed to be statistically significant.
Additional files
Additional file 1: DNA fingerprinting profile of HK1 cells.
Additional file 2: List of deregulated genes grouped according to
gene function or signalling pathways (≥2 fold changes; raw Ct < 35).
Additional file 3: Identification of CSCs in NPC using various
approaches.
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